WisdomTree BioRevolution Fund

Frequently Asked Questions About WDNA

What does WDNA invest in?

This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology. It's important to note that this fund is categorized as non-diversified.

What is the expense ratio of WDNA?

WisdomTree BioRevolution Fund (WDNA) charges an expense ratio of 0.45%. This is the annual fee deducted from fund assets to cover management and operations.

How big is WDNA?

WisdomTree BioRevolution Fund (WDNA) manages $2.6M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is WDNA actively managed or an index fund?

WDNA's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was WDNA launched?

WisdomTree BioRevolution Fund (WDNA) launched in June 2021 and is managed by WisdomTree.

How has WDNA performed?

WDNA's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.